Concepedia

Beate Gertz

BG

Statistics

Publications

5

Citations

71

H-Index

5

Active since

2010

Affiliations

Merck KGaA, Darmstadt (Germany)(Current)

Russian Cancer Research Center NN Blokhin

Beate Gertz is an author at Merck KGaA, Darmstadt (Germany) specializing in pharmacology, medicine, and primary efficacy endpoints.

Publications per year

2010–2017

5

Publications

5

Epoetin Theta in Anaemic Cancer Patients Receiving Platinum‐Based Chemotherapy: A Randomised Controlled Trial

Sergei Tjulandin, Peter Bias, Reiner Elsässer et al. · Archives of Drug Information · 2010 · 21 citations · Full text

, , +11

Epoetin Theta with a New Dosing Schedule in Anaemic Cancer Patients Receiving Nonplatinum-Based Chemotherapy: A Randomised Controlled Trial

Sergei Tjulandin, Peter Bias, Reiner Elsässer et al. · Archives of Drug Information · 2011 · 14 citations · Full text

, , +14

Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap® (XM17), Comparability with Gonal-f®, and Performance/Consistency

Rainer Winstel, Juergen Wieland, Beate Gertz et al. · Drugs in R&D · 2017 · 14 citations · Full text

, , +14

Epoetin theta: efficacy and safety of subcutaneous administration in anemic pre-dialysis patients in the maintenance phase in comparison to epoetin beta

Beate Gertz, P. Kes, A. Essaian et al. · Current Medical Research and Opinion · 2012 · 12 citations

, , +17

Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women

Andreas Lammerich, Peter Bias, Beate Gertz · International Journal of Women s Health · 2015 · 10 citations · Full text

, , +12

1–5 of 5